JP7836059B2 - 双性イオン及び難溶性物質溶解剤 - Google Patents

双性イオン及び難溶性物質溶解剤

Info

Publication number
JP7836059B2
JP7836059B2 JP2025575600A JP2025575600A JP7836059B2 JP 7836059 B2 JP7836059 B2 JP 7836059B2 JP 2025575600 A JP2025575600 A JP 2025575600A JP 2025575600 A JP2025575600 A JP 2025575600A JP 7836059 B2 JP7836059 B2 JP 7836059B2
Authority
JP
Japan
Prior art keywords
cation
carbon atoms
group
zwitterion
ch2ch2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2025575600A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2025170074A1 (https=
JPWO2025170074A5 (https=
Inventor
浩介 黒田
宏太 柴▲崎▼
健太 熊倉
雄太 斉藤
絢子 坂戸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Nyukazai Co Ltd
Kanazawa University NUC
Original Assignee
Nippon Nyukazai Co Ltd
Kanazawa University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Nyukazai Co Ltd, Kanazawa University NUC filed Critical Nippon Nyukazai Co Ltd
Publication of JPWO2025170074A1 publication Critical patent/JPWO2025170074A1/ja
Publication of JPWO2025170074A5 publication Critical patent/JPWO2025170074A5/ja
Application granted granted Critical
Publication of JP7836059B2 publication Critical patent/JP7836059B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
JP2025575600A 2024-02-09 2025-02-07 双性イオン及び難溶性物質溶解剤 Active JP7836059B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2024018970 2024-02-09
JP2024018970 2024-02-09
PCT/JP2025/004239 WO2025170074A1 (ja) 2024-02-09 2025-02-07 双性イオン及び難溶性物質溶解剤

Publications (3)

Publication Number Publication Date
JPWO2025170074A1 JPWO2025170074A1 (https=) 2025-08-14
JPWO2025170074A5 JPWO2025170074A5 (https=) 2026-03-06
JP7836059B2 true JP7836059B2 (ja) 2026-03-26

Family

ID=96700181

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025575600A Active JP7836059B2 (ja) 2024-02-09 2025-02-07 双性イオン及び難溶性物質溶解剤

Country Status (2)

Country Link
JP (1) JP7836059B2 (https=)
WO (1) WO2025170074A1 (https=)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140255861A1 (en) 2007-03-09 2014-09-11 The Regents Of The University Of Michigan Methods and compositions for growth of cells and embryonic tissue on a synthetic polymer matrix
US20190037832A1 (en) 2016-04-08 2019-02-07 Tianjin University Cell Cryopreservation Protective Composition, Use Thereof, and Cell Cryopreservation Method
WO2020230721A1 (ja) 2019-05-13 2020-11-19 国立研究開発法人科学技術振興機構 非プロトン性双性イオンを用いた未分化促進剤及び凍結保護剤

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140255861A1 (en) 2007-03-09 2014-09-11 The Regents Of The University Of Michigan Methods and compositions for growth of cells and embryonic tissue on a synthetic polymer matrix
US20190037832A1 (en) 2016-04-08 2019-02-07 Tianjin University Cell Cryopreservation Protective Composition, Use Thereof, and Cell Cryopreservation Method
WO2020230721A1 (ja) 2019-05-13 2020-11-19 国立研究開発法人科学技術振興機構 非プロトン性双性イオンを用いた未分化促進剤及び凍結保護剤

Also Published As

Publication number Publication date
JPWO2025170074A1 (https=) 2025-08-14
WO2025170074A1 (ja) 2025-08-14

Similar Documents

Publication Publication Date Title
Schmolka Artificial skin I. Preparation and properties of pluronic F‐127 gels for treatment of burns
JP2647556B2 (ja) 改良された生物学的活性を有するポリオキシプロピレン／ポリオキシエチレン共重合体類
RU2395287C2 (ru) Раствор для профилактики спайкообразования и способ профилактики спайкообразования
JP4542300B2 (ja) ヒアルロン酸蓄積促進剤
NO20190192A1 (no) Topisk koenzyme Q10-formuleringer og anvendelse derav
KR102924306B1 (ko) 건강관리 제품을 위한 계면활성제
RU2517111C2 (ru) Способ повышения водорастворимости слаборастворимых веществ
KR20220114639A (ko) 건강관리 제품에 사용하기 위한 계면활성제
WO2003097095A1 (en) Process for the preparation and activation of substances and a means of producing same
JP7836059B2 (ja) 双性イオン及び難溶性物質溶解剤
Mohamadzadeh et al. Effect of double microemulsion on the Aga/CMC/MoS2 nano composites for drug delivery: green synthesis and physico-chemical characterization
JP7416495B2 (ja) 双性イオンを含む培地用添加剤
Aravind et al. Sustained release of curcumin from fibrin matrix induces cancer cell death and immunomodulation
EA010315B1 (ru) Эмульсия перфторорганических соединений медицинского назначения и способ ее получения
WO2003022265A1 (en) Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof
EP2211872A1 (en) Hyperbranched polyglycerol for improving heart function
CN115813781A (zh) 一种改性氧化白藜芦醇及其制备方法和应用
JP5909796B2 (ja) 難溶性物質の水溶解性改善方法
Wei et al. High drug-loaded supramolecular microgels enabled by controlled in-droplet self-assembly for adaptive treatment of inflammatory arthritis
KR20230051181A (ko) 건강관리 제품에 사용하기 위한 분지형 아미노산 계면활성제
Maimansomsuk et al. The synthesis of Tween80/calcium phosphate nanocomposite bioactive gelatine-based gels as a proof of concept for tooth sensitivity home-treatment
CN106267172A (zh) 一种用于预防瘢痕的组合物及其制备方法和应用
US10357456B2 (en) Parenteral bioactive substance delivery composition based on low molecular weight methyl cellulose
JP2025091112A (ja) 皮膚外用剤組成物
Tavartkiladze et al. AminoTriComplex: Preclinical and Clinical Evidence for a Multi-Component Phytochemical Formulation Targeting Oxidative Stress, Mitochondrial Function, and Cancer-Related Pathways

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260123

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260123

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20260123

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260302

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260305

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260325

R150 Certificate of patent or registration of utility model

Ref document number: 7836059

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150